Apogee Therapeutics, Inc. Common Stock (APGE) Sentiment

30-day SentiSense Score 0.54 · Neutral · ▲ warming · as of 2026-09-07

APGE sentiment is neutral (30-day SentiSense Score 1) and strengthening from a month ago; there is no reading for today yet. Attention averages ~6 mentions/day (2 today).

Sentiment (30-day)
Neutral
SentiSense Score (30-day avg)
0.54
Mentions / day (30-day avg)
6 (2 today)

Where the conversation is happening

News
Bullish · 76% of mentions
X
Bullish · 24% of mentions

Related tickers

CLDX, DNTH, CGON, REGN

What's driving it

  • AbbVie closes its $10.9 billion Apogee Therapeutics acquisition, adding a late-stage immunology pipeline (+0.08)
  • AbbVie Acquires Apogee Therapeutics for $10.9 Billion in Cash (+0.38)
  • AbbVie Acquires Apogee Therapeutics for $10.9 Billion (+0.41)

Live SentiSense Score, sentiment history, and per-source breakdown for Apogee Therapeutics, Inc. Common Stock on SentiSense.

See how APGE's sector compares in the market sentiment heatmap